Costello Syndrome Treatments
Find Costello Syndrome Treatments
Brand Name
Tryngolza
Generic Name
Olezarsen
View Brand Information FDA approval date: December 19, 2024
Form: Injection
What is Tryngolza (Olezarsen)?
TRYNGOLZA is indicated as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome . TRYNGOLZA is an APOC-III -directed antisense oligonucleotide indicated as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome .
Approved To Treat
Top Global Experts
Save this treatment for later
Not sure about your diagnosis?
Tired of the same old research?
Related Clinical Trials
There is no clinical trials being done for this treatment